kabutan

Solasia Pharma, Jan-Sep (Cumulative 3Q) Net Income Loss Narrows, Jul-Sep Net Income Loss Narrows

Fri Nov 14, 2025 3:30 pm JST Earnings

4597 Solasia Pharma K.K. 【IFRS】

Earnings Report

Solasia Pharma K.K. <4597> [TSE Growth] announced its financial results (based on IFRS) after the market closed on November 14th (15:30). The consolidated net loss for the cumulative third quarter of the fiscal year ending December 2025 (January to September) was a reduced loss of 0.72 billion yen (compared to a loss of 0.87 billion yen in the same period last year).

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net income/loss for the October to December period (4Q) is expected to turn into a profit of 0.07 billion yen (compared to a loss of 1.07 billion yen in the same period last year).

In the most recent three-month period, from July to September (3Q), the consolidated net loss improved to a deficit of 0.17 billion yen (compared to a loss of 0.26 billion yen in the same period last year). The operating profit/loss margin improved from -3122.2% in the same period last year to -419.0%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2023 602 -787 -784 -768 -4.6 ー Nov 13, 2023 IFRS
Jan - Sep, 2024 81 -892 -892 -871 -4.5 ー Nov 13, 2024 IFRS
Jan - Sep, 2025 91 -713 -725 -726 -3.2 ー Nov 14, 2025 IFRS
YoY +12.3% +20.1% +18.7% +16.6% +30.2%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2024 244 -1,340 -1,334 -1,330 -6.7 0 Feb 12, 2025 IFRS
Jul - Dec, 2025 Guidance 1,251 -113 -95 -95 -0.4 0 Aug 13, 2025 IFRS
YoY +412.7% +91.6% +92.9% +92.9% +94.5%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 617 -1,139 -1,135 -1,112 -6.6 0 Feb 14, 2024 IFRS
Dec, 2024 316 -1,951 -1,961 -1,941 -9.8 0 Feb 12, 2025 IFRS
Dec, 2025 Guidance 1,300 -650 -650 -650 -2.5 0 Feb 12, 2025 IFRS
YoY +311.4% +66.7% +66.9% +66.5% +74.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jul - Sep, 2024 9 -281 -265 -260 -1.4 -3,122.2 Nov 13, 2024 IFRS
Oct - Dec, 2024 235 -1,059 -1,069 -1,070 -5.4 -450.6 Feb 12, 2025 IFRS
Jan - Mar, 2025 25 -296 -292 -292 -1.3 -1,184.0 May 14, 2025 IFRS
Apr - Jun, 2025 24 -241 -263 -263 -1.2 -1,004.2 Aug 13, 2025 IFRS
Jul - Sep, 2025 42 -176 -170 -171 -0.7 -419.0 Nov 14, 2025 IFRS
YoY +366.7% +37.4% +35.8% +34.2% +45.2%

Related Articles